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Objective: To study the effect of trigonelline on the change of indicators of serum
transaminase, lipoprotein and liver lipid of model rats with non-alcoholic fatty liver
diseases and on the expression level of Bcl-2 and Bax proteins.
Methods: A total of 45 SD rats were randomly divided into the control group, model
group and trigonelline intervention group. Rats in the control group were fed with the
common diet, while rats in the model group and intervention group were fed with the high
fat diet. 8 weeks later, the intervention group received the intragastric administration of
trigonellin e (with the dosage of 40 mg/kg/d) for 8 weeks; while control group and model
group received the intragastric administration of saline with the equal dosage. Blood was
taken from the abdominal aorta of rats 8 weeks later, detecting the level of a series of
indicators of ALT, AST, TG, TC, HDL-C and LDL-C in the serum. After the rats were
sacriﬁced, detect the indicators of TG, TC, SOD and MDA in the liver tissue of rats, as
well as the expression of Bcl-2 and Bax in the liver tissue.
Results: Results of histopathologic examination showed that the damage degree of liver
for rats in the trigonelline intervention group was smaller than the one in the model group,
with signiﬁcantly reduced hepatic steatosis and the partially visible hepatic lobule. The
levels of ALT, AST, TC and LDL-C in the serum of rats in the trigonelline group were
signiﬁcantly reduced, while the change in the levels of TG and HDL-C was not signif-
icantly different. The levels of TG, TC and MDA in the liver tissues were signiﬁcantly
decreased, while the level of SOD signiﬁcantly increased; the expression of Bcl-2 protein
in the liver tissues of rats in the trigonelline intervention group was signiﬁcantly
increased, while the expression of Bax protein signiﬁcantly decreased.
Conclusions: The trigonelline contributes to the therapeutic effect of non-alcoholic fatty
liver diseases. It can also increase the expression of Bcl-2 protein and decrease the
expression of Bax protein in the liver tissues, which can protect the liver.1. Introduction
In recent years, the incidence of non-alcoholic fatty liver
diseases (NAFLD) and non-alcoholic steatohepatitis isincreasing year by year [1,2] and there is no medicine with the
proved effect at the moment. In China, with the increased
living standard, dietary structure and lifestyle of Chinese
people show great change, while the incidence of NAFLD
shows the tendency of increase year by year [3,4]. NAFLD is a
sort of metabolic syndrome and its pathological features
include the degeneration of liver cells and lipid particles in the
liver cells [5].
Trigonelline is one of major alkaloids that exists in the seeds
of fenugreek, is also the main effective component of such seeds
[6,7]. According to the modern medical researchers, the
trigonelline can reduce the blood sugar and cholesterol, hasarticle under the CC BY-NC-ND
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neural tissues [8–10], but there is no research on the effect of
trigonelline on NAFLD. This study took the lipid oxidation
and cell apoptosis as the starting point, fed SD rats with high-
fat diet for the preparation of NAFLD model, then discussed
the speciﬁc mechanism of trigonelline and the effect on liver of
NAFLD rats.
2. Materials and methods
2.1. Preparation of animal model and grouping
After one week of adaptive feeding, 45 SPF-level SD male
rats were randomly divided into 3 groups, with 15 subjects in
each group, including the control group, model group and
intervention group. Rats in the control group were fed with the
normal diet, while rats in the model group and intervention
group were fed with the high fat diet for 8 weeks. Eight weeks
later, the intervention group received the intragastric adminis-
tration of trigonelline (with the dosage of 40 mg/kg/d) for 8
weeks; while control group and model group received the
intragastric administration of saline with the equal dosage.
2.2. Detection of biochemical indicators in blood
After the ﬁnal feeding, rats in each group were fasted for
12 h. A total of 15 experimental animals were taken from the
control group, model group and intervention group respectively
for the blood collection from the abdominal aorta. The levels of
a series of indicators of ALT, AST, TC, TG, HDL-C and LDL-C
in the serum were detected.
2.3. Detection of Bcl-2 and Bax
Parts of liver tissues were cut off for the detection of liver
lipid, while other part of liver tissues for the detection of Bcl-2
and Bax. They were stored in the refrigerator at −80 C.
2.4. Western blot test
Samples of liver tissues were unfrozen. RIPA lysis buffer
was chosen for the cell lysis. The loading buffer was added.
After being boiled, the polyacrylamide gel electrophoresis was
performed to separate the protein. After the electrophoresis, the
protein was transferred on the gel to PVDF ﬁlm. When it was
ﬁnished, the PVDF ﬁlm was blocked using the solution with 5%
skimmed milk powder for 1 h. The concentration of 1:200 was
set to dilute the primary antibody of Bcl-2 and Bax (the primaryFigure 1. Results of histopathological sections of liver tissues of rats in eachantibody of Bcl-2 was purchased from Santa Cruz, with the item
number of sc-492; the primary antibody of Bax was purchased
from Santa Cruz, with the item number of sc-493; the primary
antibody of b-actin was purchased from Santa Cruz, with the
item number of sc-1616). The overnight incubation was per-
formed at 4 C. On the next day, PBST was used to wash PVDF
ﬁlm for 3 times and then the secondary antibody was added for
the incubation. Finally, the chemiluminescence solution pur-
chased from Millipore was employed for the coloration and the
chemiluminescence apparatus (purchased from Biorad) for the
detection.
2.5. Statistical analysis
The experimental data was expressed by mean ± SD.
SPSS17.0 was employed for the analysis of variance between
groups. The t test was used for the comparison of means be-
tween two groups, while P < 0.05 was considered as the sig-
niﬁcant difference.
3. Results
3.1. Pathological slices of liver tissues of NAFLD rats
According to the visual inspection, the liver morphology of
rats in the control group, showed the normal size, soft texture
and red color; while the liver of rats in the model group showed
the increased volume, hard texture, relatively oily section and
creamy yellow color. The liver of rats in the trigonelline inter-
vention group was better than the one in the model group,
showing the light red surface. As shown in Figure 1, the liver
cells of rats in the control group showed the normal structure and
clearly visible hepatic lobule, without any obvious inﬂamma-
tion, steatosis or necrosis; a great number of liver cells in the
liver tissue of rats in the model group showed the steatosis and
invisible hepatic lobule, with a great number of lipid droplets in
the cytoplasm. The damage of liver cells of rats in the trig-
onelline intervention group was signiﬁcantly relieved and only
part of liver cells showed the steatosis, with the smaller lipid
droplet and the certain amount of hepatic lobule.
3.2. Changes in AST, ALT, TC, TG, HDL-C and LDL-C
in the serum
As shown in Table 1, compared with the control group, rats
in the model group showed the signiﬁcantly increased level of
AST, ALT, TC and LDL-C in the serum, signiﬁcantly decreased
level of HDL-C, but no signiﬁcant difference in the level of TG.group (×400).
Table 1
Comparison of AST, ALT, TC, TG, HDL-C and LDL-C in the serum of rats (n = 7).
Group AST (mkat/L) ALT (mkat/L) TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C (mmol/L)
Control group 2.185 ± 0.173 0.359 ± 0.124 1.25 ± 0.21 0.92 ± 0.22 1.12 ± 0.15 0.18 ± 0.05
Model group 4.238 ± 0.702* 1.037 ± 0.112* 3.51 ± 0.72* 1.15 ± 0.14 0.61 ± 0.07* 0.71 ± 0.19*
Intervention group 3.301 ± 0.215# 0.796 ± 0.083# 1.72 ± 0.57# 1.07 ± 0.20 0.78 ± 0.16 0.41 ± 0.11#
Note: Compared with the control group, *P < 0.05; compared with the model group, #P < 0.05.
Table 2
Effect of trigonelline on levels of TG, TC, SOD and MDA in liver issues of NAFLD Rats (n = 7).
Group TG (mmol/L) TC (mmol/L) SOD (U/mgprot) MDA (nmol/mgprot)
Control group 1.65 ± 0.33 1.12 ± 0.33 376 ± 42 1.53 ± 0.23
Model group 3.85 ± 0.25* 1.83 ± 0.76* 201 ± 32* 3.81 ± 1.42*
Intervention group 2.55 ± 0.36# 1.31 ± 0.64# 282 ± 36# 1.79 ± 0.61#
Note: Compared with the control group, *P < 0.05; compared with the model group, #P < 0.05.
Table 3
Expression of proteins of Bcl-2 and Bax.
Group Bcl-2/b-actin Bax/b-actin Bcl-2/Bax
Control group 0.56 ± 0.13 0.58 ± 0.17 0.95 ± 0.21
Model group 0.25 ± 0.08* 0.93 ± 0.13* 0.37 ± 0.15*
Intervention group 0.39 ± 0.15# 0.67 ± 0.16# 0.55 ± 0.22#
Note: Compared with the control group, *P < 0.05; compared with the
model group, #P < 0.05.
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showed the signiﬁcant decreased levels of AST, ALT, TC and
LDL-C in the serum, but no signiﬁcant change in the levels of
HDL-C and TG. Thus the trigonelline could signiﬁcantly reduce
the levels of AST, ALT, TC and LDL-C in the serum of
modeled rats, but have limited effect on HDL-C and TG, which
indicated that the trigonelline could protect the liver.
3.3. Change in TG, TC, SOD, MDA
As shown in Table 2, levels of TG, TC and MDA in the liver
tissues of rats in the model group were signiﬁcantly increased
than the one in the control group, while the level of SOD
decreased. After the treatment of trigonelline, levels of TG, TC
and MDA in the liver tissues of rats in the intervention group
were signiﬁcantly reduced than the one in the model group,
while the level of SOD showed the signiﬁcant increase.
3.4. Expression of Bcl-2 and Bax
The expression of Bcl-2 in rats of model group was lower
than the one in the control group, while the expression of Bax
was higher. After the treatment of trigonelline, the expression of
Bcl-2 in rats of intervention group was signiﬁcantly higher than
the one in the model group, while the expression of Bax was
lower (Figure 2, Table 3).Figure 2. Expression of Bcl-2 and Bax gene.4. Discussion
The trigonelline is a sort of alkaloid. Recent researches
showed that the trigonelline possesses the functions of anti-
oxidation and can reduce the blood sugar and cholesterol [11–13],
but there is no research on the therapeutic effect of trigonelline
against NAFLD. In this study, results of pathological detection
showed that the damage degree of liver of rats in the
trigonelline intervention group was reduced and steatosis rate
of liver cells was also signiﬁcantly decreased than the model
group, with the visible hepatic lobule. Besides, the levels of
ALT, AST, TC and LDL-C in the serum were signiﬁcantly
decreased, as well as the levels of TG, TC and MDA in the liver
tissues, but the level of SOD was increased. These results all
indicate that the trigonelline can effectively improve the symp-
toms of NAFLD. So far as we know, it is the ﬁrst study to adopt
the trigonelline in the treatment of NAFLD, evaluate a series of
indicators of liver and also preliminarily conﬁrm the protection
mechanism of trigonelline for the liver with NAFLD.
The hepatocyte apoptosis is closely related to the diseases
such as the inﬂammation and ﬁbrosis, as well as the occurrence
and development of NAFLD. In the signal transduction of
apoptosis, the component ratio of Bcl-2 family members is the
critical factor to regulate the apoptosis, where Bcl-2 and Bax are
the typical members of Bcl-2 family and the ratio between them
Bcl-2/Bax is regarded as the “molecular switch” to start the
apoptosis [14].
Bcl-2 gene is also named as the apoptosis inhibition gene.
According to the immunohistochemical staining and electron
microscopic observation, Bcl-2 is mainly distributed in the
endoplasmic reticulum membrane, outer mitochondrial mem-
brane and perinuclear membrane, which can resist the stimula-
tion of apoptosis and thus play the role of protection for cells.
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the occurrence of apoptosis [15,16]. Bax (Bcl-2 associated protein
X) is distributed in the cytoplasm, intracellular membrane and
nucleus. The high expression of such gene is the indication of
apoptosis. The normal liver tissue shows the certain
expression of Bcl-2 and Bax and its ratio between Bcl-2/Bax
keeps balanced. In case of the apoptosis, such ration would be
disordered [17]. This study adopts the experimental techniques
of molecular biology to detect the function of trigonelline.
Results showed that, compared with the model group, the
expression of Bcl-2 in the liver tissue of rats in the trigonel-
line intervention group was signiﬁcantly increased, with the
signiﬁcant decrease in the expression of Bax and the signiﬁcant
increase in the ratio Bcl-2/Bax, but still lower than the one in the
control group. It indicates that the trigonelline may affect the
relative expression of Bcl-2 and Bax in the liver tissues and thus
reduce the hepatocyte apoptosis and realize the treatment of
NAFLD. This research will provide the reference for our further
exploration in the treatment of NAFLD using trigonelline. In the
succeeding works, we will continue to evaluate the effect of
trigonelline in the treatment of NAFLD.
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